Earnings Feed
Start Free
Home/Filings/4/0001209191-15-049287
4//SEC Filing

RXi Pharmaceuticals Corp 4

Accession 0001209191-15-049287

$PHIOCIK 0001533040operating
View on SEC.govCompany Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 8:04 AM ET

Size

9.0 KB

Accession

0001209191-15-049287

Insider Transaction Report

Form 4
Period: 2015-06-02
RXi Pharmaceuticals CorpRXII
Pavco Pamela
Chief Development Officer
Transactions
  • Award

    Overallotment purchase right

    2015-06-02+6,250→ 6,250 total
    Exercise: $0.46From: 2015-06-02Exp: 2016-07-02→ Common stock (6,250 underlying)
  • Award

    Common stock, $0.0001 par value

    2015-06-02$0.40/sh+12,500$5,000→ 33,718 total
  • Award

    Common stock purchase warrant

    2015-06-02+6,250→ 6,250 total
    Exercise: $0.52From: 2015-06-02Exp: 2020-06-02→ Common stock (6,250 underlying)

Documents

1 file

Issuer

RXi Pharmaceuticals Corp

CIK 0001533040

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001533040

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 8:04 AM ET
Size
9.0 KB
View on SEC.gov